Navigation Links
Dr. Brian Mehling Talks Stem Cells at China's Taishan Academic Forum

NEW YORK, Nov. 26, 2013 /PRNewswire/ -- Dr. Brian Mehling, New York-based orthopedic surgeon and founder of Blue Horizon International, spoke Sunday in Shangdong, China at the 2013 Taishan Academic Forum International Conference on Hematopoietic Stem Cells and Leukemia.

Over 200 Chinese doctors and graduate students also attended the Taishan Academic Forum 2013 International Conference, sponsored by the Weifang Medical University in Shangdong.  They discussed the use of stem cell treatments for chronic conditions and acute diseases, and how such treatments have changed the face of global health care, allopathic medicines and traditional Chinese medicines.

"Stem cell treatments are without a doubt the future of medicine," stated Dr. Mehling.  "It is very important that young doctors learn about the possibilities in stem cell research, and also about the treatments that are already available for patients with different chronic conditions.

Blue Horizon International is a health care consulting company which combines cutting edge medical treatment and research with philanthropy.  BHI provides resources and services to children and adults of all backgrounds, but especially those who are medically underserved.  BHI subsidiaries have successfully performed over 2000 documented stem cell procedures on over 500 patients to date.  For more information please visit Blue Horizon International at

Media Contact:
Odd Einer


SOURCE Blue Horizon International
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Proove Biosciences CEO Brian Meshkin Wins 2013 Bridging the Gap Award by the Greater Baltimore Committee
2. Proove CEO and Vice Chairman of the Howard County Board of Education, Brian Meshkin, Selected as one of Howard County's Finest Under 39 by the Cystic Fibrosis Foundation
3. Verenium Announces Appointment Of Brian Carter As Vice President Of Grain Processing
4. Brian Cousins Joins Opedix Joint Support Athletic Wear as Vice President of Business Development
5. Shark Branding Corp. CEO Daymond John and Fuse Science CEO Brian Tuffin to be interviewed on Bloomberg Televisions "Taking Stock with Pimm Fox"
6. Brain Research Foundation 2013 Scientific Innovations Awards To Dr. Jean Hebert and Dr. Brian Litt
7. Pharmacovigilance Benefit-Risk Assessments: Requirements, Transparency, and Implications, a New and Upcoming Drug Safety Webinar Hosted by Xtalks
8. Respiratory Update: Interpreting Minimal Clinically Important Differences in COPD and Demonstrating Product Value with PROs, a New Life Science webinar Hosted by Xtalks
9. Pharmacovigilance: ADR Management and Reporting & Outsourcing Trends, A New Drug Safety Webinar from Xtalks
10. Data-driven Site Negotiations: Fast Track to Fair Market Value (FMV), a New Clinical Trials Webinar from Xtalks
11. Market Access and Pipeline Development – How Healthcare Modeling Can Make a Difference, a Pharmaceutical Market Strategy Webinar from Xtalks
Post Your Comments:
(Date:6/23/2016)... Calif. , June 23, 2016  Blueprint Bio, ... biological discoveries to the medical community, has closed its ... Matthew Nunez . "We have received ... with the capital we need to meet our current ... essentially provide us the runway to complete validation on ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... -- Amgen (NASDAQ: AMGN ) today announced a ... sciences incubator to accelerate the development of new therapies ... QB3@953 was created to help high-potential life science and ... stage organizations - access to laboratory infrastructure. ... "Amgen Golden Ticket" awards, providing each winner with one ...
(Date:6/22/2016)... , June 22, 2016 Research and ... Global Markets" report to their offering. ... billion in 2014 from $29.3 billion in 2013. The market is ... of 13.8% from 2015 to 2020, increasing from $50.6 billion in ... projected product forecasts during the forecast period (2015 to 2020) are ...
Breaking Biology Technology:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
Breaking Biology News(10 mins):